Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
67
CWBHF Quote, Financials, Valuation and Earnings
Last price:
$0.37
Seasonality move
:
-11.12%
Day range:
$0.34 - $0.39
52-week range:
$0.05 - $0.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.20x
P/B ratio:
6.43x
Volume:
229.3K
Avg. volume:
1.3M
1-year change:
193.24%
Market cap:
$59.5M
Revenue:
$49.7M
EPS (TTM):
-$0.14
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$12.8M | -- | -19.22% | -- | -- |
|
FOLD
Amicus Therapeutics, Inc.
|
$179.8M | $0.16 | 20.08% | 234.42% | $14.83 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.37 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$0.37 | -- | $59.5M | -- | $0.00 | 0% | 1.20x |
|
FOLD
Amicus Therapeutics, Inc.
|
$14.28 | $14.83 | $4.4B | -- | $0.00 | 0% | 7.31x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$9.46 | $0.85 | $1.2B | 15.89x | $0.80 | 0% | 18.38x |
|
OGEN
Oragenics, Inc.
|
$0.85 | $2.00 | $699.5K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.22 | $7.00 | $7.4M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
87.16% | -0.492 | 232.04% | 1.23x |
|
FOLD
Amicus Therapeutics, Inc.
|
65.77% | -0.323 | 18.22% | 1.91x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | -3.190 | 8.08% | 1.85x |
|
OGEN
Oragenics, Inc.
|
3.86% | 0.905 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -2.522 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$3.8M | -$5.3M | -26.51% | -105.72% | -45.68% | -$5.5M |
|
FOLD
Amicus Therapeutics, Inc.
|
$147.7M | $34.3M | -2.18% | -7.02% | 20.27% | $35.3M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
Charlotte's Web Holdings, Inc. vs. Competitors
-
Which has Higher Returns CWBHF or FOLD?
Amicus Therapeutics, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of 10.24%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Amicus Therapeutics, Inc.'s return on equity of -7.02%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M FOLDAmicus Therapeutics, Inc.87.38% $0.06 $673.2M -
What do Analysts Say About CWBHF or FOLD?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -32.98%. On the other hand Amicus Therapeutics, Inc. has an analysts' consensus of $14.83 which suggests that it could grow by 3.88%. Given that Amicus Therapeutics, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Amicus Therapeutics, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 FOLDAmicus Therapeutics, Inc.2 5 0 -
Is CWBHF or FOLD More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.165, which suggesting that the stock is 16.492% more volatile than S&P 500. In comparison Amicus Therapeutics, Inc. has a beta of 0.417, suggesting its less volatile than the S&P 500 by 58.311%.
-
Which is a Better Dividend Stock CWBHF or FOLD?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amicus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Amicus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or FOLD?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are smaller than Amicus Therapeutics, Inc. quarterly revenues of $169.1M. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than Amicus Therapeutics, Inc.'s net income of $17.3M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Amicus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 1.20x versus 7.31x for Amicus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.1.20x -- $11.5M -$5.8M FOLDAmicus Therapeutics, Inc.7.31x -- $169.1M $17.3M
-
Which has Higher Returns CWBHF or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of -255.85%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About CWBHF or NBY?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -32.98%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -91.02%. Given that NovaBay Pharmaceuticals, Inc. has more downside risk than Charlotte's Web Holdings, Inc., analysts believe Charlotte's Web Holdings, Inc. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is CWBHF or NBY More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.165, which suggesting that the stock is 16.492% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.093, suggesting its less volatile than the S&P 500 by 90.725%.
-
Which is a Better Dividend Stock CWBHF or NBY?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or NBY?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 15.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 1.20x versus 18.38x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.1.20x -- $11.5M -$5.8M NBYNovaBay Pharmaceuticals, Inc.18.38x 15.89x $521K -$1.3M
-
Which has Higher Returns CWBHF or OGEN?
Oragenics, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of --. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About CWBHF or OGEN?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -32.98%. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 135.29%. Given that Oragenics, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Oragenics, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 OGENOragenics, Inc.1 0 0 -
Is CWBHF or OGEN More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.165, which suggesting that the stock is 16.492% more volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.685%.
-
Which is a Better Dividend Stock CWBHF or OGEN?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or OGEN?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are larger than Oragenics, Inc. quarterly revenues of --. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 1.20x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.1.20x -- $11.5M -$5.8M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns CWBHF or PTN?
Palatin Technologies has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of --. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M PTNPalatin Technologies-- -- -- -
What do Analysts Say About CWBHF or PTN?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -32.98%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Palatin Technologies is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 PTNPalatin Technologies0 0 0 -
Is CWBHF or PTN More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.165, which suggesting that the stock is 16.492% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock CWBHF or PTN?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or PTN?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are larger than Palatin Technologies quarterly revenues of --. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is higher than Palatin Technologies's net income of --. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 1.20x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.1.20x -- $11.5M -$5.8M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns CWBHF or TOVX?
Theriva Biologics, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of --. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About CWBHF or TOVX?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -32.98%. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3090.52%. Given that Theriva Biologics, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Theriva Biologics, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is CWBHF or TOVX More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.165, which suggesting that the stock is 16.492% more volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.343, suggesting its less volatile than the S&P 500 by 65.729%.
-
Which is a Better Dividend Stock CWBHF or TOVX?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or TOVX?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are larger than Theriva Biologics, Inc. quarterly revenues of --. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 1.20x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.1.20x -- $11.5M -$5.8M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
